RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB

BACKGROUND: Ependymoma is a rare tumor for which the role of chemotherapy has not been established either for newly diagnosed or recurrent disease. We report on the first prospective adult clinical trial of chemotherapy for recurrent ependymoma. METHODS: Adult (> 18 years) were treated with dose-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Armstrong, Terri, Yuan, Ying, Wu, Jimin, Mendoza, Tito, Vera, Elizabeth, Omuro, Antonio, Lieberman, Frank, Robins, H, Gerstner, Elizabeth, Wu, Jing, Wen, Patrick, Mikkelsen, Tom, Aldape, Kenneth, Gilbert, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217700/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.998
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados